$PKTX
ProtoKinetix, Inc.

2022 Q4 Form 10-K Financial Statement

#000107997323000353 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $505.6K $1.400M $1.890M
YoY Change 143.11% -25.94% -73.43%
% of Gross Profit
Research & Development $21.91K $448.9K $435.9K
YoY Change -88.19% 2.98% -17.34%
% of Gross Profit
Depreciation & Amortization $56.20K $58.45K $3.000K
YoY Change 7393.33% 1848.33% 0.0%
% of Gross Profit
Operating Expenses $583.7K $1.907M $2.329M
YoY Change 48.08% -18.12% -69.53%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$583.7K -$1.907M -$2.329M
YoY Change 48.08% -18.12% -69.53%
Income Tax
% Of Pretax Income
Net Earnings -$583.7K -$1.907M -$2.329M
YoY Change 48.08% -18.12% -69.53%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share $0.00 -$0.01 -$7.981K
COMMON SHARES
Basic Shares Outstanding 314.3M shares 307.4M shares
Diluted Shares Outstanding 307.4M shares

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.55K $25.55K $57.57K
YoY Change -55.62% -55.62% -70.24%
Cash & Equivalents $25.55K
Short-Term Investments
Other Short-Term Assets $1.050K $1.050K $26.00K
YoY Change -95.96% -95.96% 2376.19%
Inventory
Prepaid Expenses $1.050K
Receivables
Other Receivables
Total Short-Term Assets $26.60K $26.60K $83.56K
YoY Change -68.17% -68.17% -57.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $436.3K $436.3K $362.7K
YoY Change 20.29% 20.29% 32.03%
TOTAL ASSETS
Total Short-Term Assets $26.60K $26.60K $83.56K
Total Long-Term Assets $436.3K $436.3K $362.7K
Total Assets $462.9K $462.9K $446.2K
YoY Change 3.73% 3.73% -4.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $41.53K $41.53K $93.27K
YoY Change -55.47% -55.47% 245.44%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.53K $41.53K $93.27K
YoY Change -55.47% -55.47% 107.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $41.53K $41.53K $93.27K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $41.53K $41.53K $93.27K
YoY Change -55.47% -55.47% 107.45%
SHAREHOLDERS EQUITY
Retained Earnings -$47.45M
YoY Change 4.19%
Common Stock $1.726K
YoY Change 8.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $421.3K $421.3K $353.0K
YoY Change
Total Liabilities & Shareholders Equity $462.9K $462.9K $446.2K
YoY Change 3.73% 3.73% -4.89%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income -$583.7K -$1.907M -$2.329M
YoY Change 48.08% -18.12% -69.53%
Depreciation, Depletion And Amortization $56.20K $58.45K $3.000K
YoY Change 7393.33% 1848.33% 0.0%
Cash From Operating Activities -$147.2K -$804.7K -$889.9K
YoY Change -37.03% -9.58% 0.97%
INVESTING ACTIVITIES
Capital Expenditures $57.49K $132.1K -$90.99K
YoY Change -339.44% -245.13% 29.65%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$57.49K -$132.0K -$90.99K
YoY Change 139.44% 45.12% 29.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $904.7K $845.0K
YoY Change 7.07% 10.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 186.5K $904.7K 845.0K
YoY Change 9.71% 7.07% 10.09%
NET CHANGE
Cash From Operating Activities -147.2K -$804.7K -889.9K
Cash From Investing Activities -57.49K -$132.0K -90.99K
Cash From Financing Activities 186.5K $904.7K 845.0K
Net Change In Cash -18.16K -$32.02K -135.9K
YoY Change -79.3% -76.44% -26.12%
FREE CASH FLOW
Cash From Operating Activities -$147.2K -$804.7K -$889.9K
Capital Expenditures $57.49K $132.1K -$90.99K
Free Cash Flow -$204.7K -$936.7K -$798.9K
YoY Change -2.41% 17.25% -1.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001128189
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 PKTX Issuance Of Common Stock Pursuant To Cashless Option Exercise Amount
IssuanceOfCommonStockPursuantToCashlessOptionExerciseAmount
usd
CY2021 PKTX Extension Of Terms Of Warrants
ExtensionOfTermsOfWarrants
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 PKTX There Were No Noncash Financing Or Investing Activities.
ThereWereNoNoncashFinancingOrInvestingActivities.
usd
CY2021 PKTX There Were No Noncash Financing Or Investing Activities.
ThereWereNoNoncashFinancingOrInvestingActivities.
usd
CY2022Q4 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-32917
CY2022 dei Entity Registrant Name
EntityRegistrantName
PROTOKINETIX, INCORPORATED
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
322880151 shares
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
25550 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
57568 usd
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3355026
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
109 W Main St
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Dalton
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44618
CY2022 dei City Area Code
CityAreaCode
330
CY2022 dei Local Phone Number
LocalPhoneNumber
455-4971
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
731
CY2022 dei Auditor Name
AuditorName
Davidson & Company LLP
CY2022 dei Auditor Location
AuditorLocation
Vancouver, British Columbia, Canada
CY2022Q2 dei Entity Public Float
EntityPublicFloat
9886980 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
26600 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
83563 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
436270 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
CY2022Q4 us-gaap Assets
Assets
462870 usd
CY2021Q4 us-gaap Assets
Assets
446234 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
41530 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
93268 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41530 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
93268 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
322880151 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
322880151 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
297393485 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
297393485 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1726 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1591 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47868093 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45892545 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47448479 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45541170 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
421340 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462870 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446234 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58450 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
162749 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
316995 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
166254 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
160388 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
448873 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
435872 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1070983 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1413055 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1907309 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
2329310 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1907309 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2329310 usd
CY2022 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2021 PKTX Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2022 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
307392069 shares
CY2021 PKTX Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
291865922 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
424221 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1413055 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
570000 usd
CY2021 PKTX Issuance Of Common Stock Pursuant To Warrant Exercise
IssuanceOfCommonStockPursuantToWarrantExercise
275000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-2329310 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
352966 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1070983 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
904700 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1907309 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
421340 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1907309 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2329310 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58450 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000 usd
CY2022 PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
1070983 usd
CY2021 PKTX Fair Value Of Compensatory Options Granted
FairValueOfCompensatoryOptionsGranted
1413055 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-24945 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
24945 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51738 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
48309 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-804669 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-889891 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132049 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
90985 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132049 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90985 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
904700 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
845000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
904700 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
845000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-32018 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-135877 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57568 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193445 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25550 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57568 usd
CY2015 PKTX Payment To Acquire Intangible Assets
PaymentToAcquireIntangibleAssets
30000 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_z65letlogcv" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_860_zieBtfgy8hSi">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity- related instruments issued, deferred income taxes and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
1050 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
1050 usd
CY2021Q4 PKTX Deposit Shareholder Meeting
DepositShareholderMeeting
24945 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25995 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
291186 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
90985 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
382171 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
132049 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
514220 usd
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16500 usd
CY2021 PKTX Amortization
Amortization
3000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19500 usd
CY2022 PKTX Amortization
Amortization
58450 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77950 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
362671 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
436270 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58450 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132049 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
103540000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
78890000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0350 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0255 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4343 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4356 pure
CY2022 PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
CY2021 PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
CY2022 PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021 PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P5Y1M2D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94290000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94290000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13300000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0350 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4343 pure
CY2022 PKTX Expected Forfeiture Rate
ExpectedForfeitureRate
0.0000 pure
CY2022 PKTX Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q4 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
500000000 shares
CY2021Q4 PKTX Common Stock Shares Authorizeds
CommonStockSharesAuthorizeds
400000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2022Q4 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2021Q4 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
555556 shares
CY2021Q4 PKTX Class Of Warrant Or Right Outstandings
ClassOfWarrantOrRightOutstandings
1440000 shares
CY2020Q4 PKTX Class Of Warrant Or Right Outstandings
ClassOfWarrantOrRightOutstandings
3355429 shares
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
60000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
5250000 shares
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
638227 usd
CY2021 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
722822 usd
CY2022 PKTX Modification Incremental Fair Value Option
ModificationIncrementalFairValueOption
1070983 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1907309 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2329310 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
400535 usd
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
489155 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
224907 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
296742 usd
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
75628 usd
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
92414 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
100000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
100000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6400000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6300000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6400000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6300000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
30500000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
30000000 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
6400000 usd
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
6300000 usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2000000 shares

Files In Submission

Name View Source Status
0001079973-23-000353-index-headers.html Edgar Link pending
0001079973-23-000353-index.html Edgar Link pending
0001079973-23-000353.txt Edgar Link pending
0001079973-23-000353-xbrl.zip Edgar Link pending
dheader.jpg Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex4x4.htm Edgar Link pending
ex4x5.htm Edgar Link pending
ex4x6.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
footer.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pktx-20221231.xsd Edgar Link pending
pktx_10k-123122.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pktx-20221231_cal.xml Edgar Link unprocessable
pktx-20221231_def.xml Edgar Link unprocessable
pktx-20221231_lab.xml Edgar Link unprocessable
pktx-20221231_pre.xml Edgar Link unprocessable
pktx_10k-123122_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending